Veterinary Anti Infectives Market Anticipated To Reach US$ 5,221.2 Mn By 2025

In recent years, reports of deadly animal disease outbreaks have become more
recurrent. These diseases are not only a threat to the existence of many wild species
but also lead to substantial livestock losses. The prevention and treatment of such
diseases are key market indicators for veterinary therapeutics including veterinary
anti-infectives. In its latest report, Persistence Market Research has projected that the
global veterinary anti-infectives market will expand at a CAGR of 4.1% over the
forecast period (2017–2025) and reach a valuation of US$ 5,221.2 Mn by 2025-end.
Increasing demand for anti-microbial agents is expected to contribute significantly
towards the growth of market revenue in the near future. The rise in livestock
population can boost the demand for veterinary therapeutics globally. In 2014, the
Food and Agriculture Organization of the United Nations estimated the global cattle
count at over 1.5 billion. These figures are further expected to grow substantially due
to rapidly growing demand for livestock.
Request to view table of content @
North America is currently the largest veterinary anti-infectives market and is
estimated to represent 30.5% value share of the global market by 2025-end,
expanding at CAGR of 3.7%. This growth is primarily attributed to the increase in
pet ownership and demand for high-quality meat in the U.S. and Canada. Meanwhile,
Latin America will continue to be the second most attractive market during the
forecast period. The market in Asia Pacific (APAC) is projected to witness the fastest
growth over 2025.
Based on species types, use of veterinary anti-infectives medicines is relatively
higher on livestock animals as compared to pet animals. In 2016, livestock animals
accounted for more than 68% market value share, however, this figure is likely to
drop to 67.4% by 2025 end.
Antimicrobial agents currently are the most preferred drug type. By the end of
forecast period, antimicrobial agents are expected to command for 54.6% value share
of the market. Other drugs such as antifungal agents and antiviral agents are also
gaining traction owing to product improvement and effectiveness.
Based on modes of administration, the oral route is presently the most common drug
administration mode followed by the parenteral route. By the end of 2025, the oral
administration segment is projected to reach a market valuation of US$ 1,573.1 Mn.
Request Sample Report @
Veterinary clinics are projected to reaming the leading distribution channel for
veterinary anti-infectives in 2017 and beyond. Of late, veterinary hospitals and
pharmacies have emerged as the other two key distribution channels for various
veterinary drugs including anti-infectives.
Dechra Pharmaceuticals PLC, Bayer AG, Cipla Limited, Eli Lilly and Company
(Elanco Animal Health), Heska Corp (Diamond Animal Health), Merck & Co., Inc.
(Merck Animal Health), Neogen Corporation, Phibro Animal Health Corporation,
Sanofi (Merial Animal Health), Vetoquinol S.A., Virbac S.A., Zoetis, Inc., Boehringer
Ingelheim GmbH, Ceva Santé Animale, Indian Immunologicals Limited, Intas
Pharmaceuticals Limited, Norbrook Laboratories Limited, Zydus Animal Health
Limited, Ashish Life Science Private Limited, and Oceanic Pharmachem Private
Limited are some of the top players operating in the global veterinary anti-infectives
Buy Full Veterinary Anti Infectives Market Report @
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research
model is a unique collaboration of data analytics and market research methodology to
help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a
multi-disciplinary approach. At PMR, we unite various data streams from multidimensional sources. By deploying real-time data collection, big data, and customer
experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA,Canada Toll Free: 800-961-0353
Email: [email protected]